NeutriSci International Inc. (NU.V)
| Previous Close | 0.0300 |
| Open | 0.0300 |
| Bid | 0.0250 x 0 |
| Ask | 0.0300 x 0 |
| Day's Range | 0.0250 - 0.0300 |
| 52 Week Range | 0.0250 - 0.1850 |
| Volume | |
| Avg. Volume | 44,987 |
| Market Cap | 4.153M |
| Beta (5Y Monthly) | 2.04 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0110 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- CNW Group
NEUTRISCI PROVIDES UPDATE AND PARTNER PROGRESS
NeutriSci International Inc. ("NeutriSci" or the "Company") (TSXV: NU) (OTC PINK: NRXCF) (FRANKFURT: 1N9), an innovative technology company developing products, licencing, IP and technology for B2B partnerships and the nutraceutical industry, is pleased to provide the following update.
- CNW Group
NEUTRISCI ANNOUNCES VOLUNTARY DELISTING FROM OTCQB
NeutriSci International Inc. ("NeutriSci" or the "Company") (TSXV: NU) (OTCQB: NRXCF) (FSE: 1N9), an innovative technology company developing products, licensing IP and technology for B2B partnerships and the nutraceutical industry, announces that, it in order to direct capital to other activities, will voluntarily delist its common shares from trading on the OTCQB. The delisting will be effective prior to the opening of the markets on February 1, 2022.
- CNW Group
NEUTRISCI SHIPS TABLETZ ORDER TO JAPAN
NeutriSci International Inc. ("NeutriSci" or the "Company") (TSXV: NU) (OTCQB: NRXCF) (FSE: 1N9), an innovative technology company developing products, licensing IP and technology for B2B partnerships and the nutraceutical industry, is pleased to announce that it has shipped another order that was placed by Tabletz LLC, via air freight to Japan. The respective revenue will be booked in the current quarter.
